...Continued

EQS-News: Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches

Retrieved on: 
Thursday, February 2, 2023
2019–20 Serie B, Therapy, Lead Candidate, Series, ERAP2, Clinic, Safety, OXFORD, Neoplasm, ERAP, TCR, ...Continued, ERAP1, PD-1, MHC, Pharmaceutical industry, Fine chemical, Vaccine, Wolf, Andera-ye Olya

Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches

Key Points: 
  • Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches
    The issuer is solely responsible for the content of this announcement.
  • The financing was co-led by Pfizer Ventures and Earlybird Venture Capital, and also included investment from new investors Oxford Science Enterprises and British Patient Capital and existing investors Canaan and Andera Partners.
  • Proceeds will support the continued development of the company’s first-of-its-kind immuno-oncology approaches designed to overcome key resistance mechanisms through the creation of novel cancer antigens.
  • In conjunction with the financing, Grey Wolf Therapeutics has announced several new appointees to its board of directors including:

JinkoSolar Launches Second Generation Tiger Neo Family

Retrieved on: 
Tuesday, January 10, 2023
ESS, Topcon, ...Continued, Multimedia, Unmatched, CMO, Renewable energy

SHANGRAO, China, Jan. 10, 2023 /PRNewswire/ -- JinkoSolar, one of the largest and most innovative solar module manufacturers in the world, today revealed its Second Generation Tiger Neo panel family – one of the world's most efficient and powerful solar panels.

Key Points: 
  • SHANGRAO, China, Jan. 10, 2023 /PRNewswire/ -- JinkoSolar, one of the largest and most innovative solar module manufacturers in the world, today revealed its Second Generation Tiger Neo panel family – one of the world's most efficient and powerful solar panels.
  • The upgraded Tiger Neo family includes three series with up to 445Wp for 54-cell, 615Wp for 72-cell, and 635Wp for 78-cell and module efficiency up to 22.27%, 23.23%, and 22.72% respectively.
  • This generation of Tiger Neo panels built on the record highly efficient N-type TOPCon technology delivers improved performance and reliability that results in:
    * One of the world's most efficient and powerful panels: Available with up to 23.23% efficiency at the module level, and 615Wp power output for the 72-cell panel in 182" format.
  • * Continued advances in bifacial factor: With up to an 85% bifacial factor, it can push a higher generation on the rear side panel and allow for 15-20% more yield compared to conventional bifacial panels.

JinkoSolar Launches Second Generation Tiger Neo Family

Retrieved on: 
Tuesday, January 10, 2023
ESS, Topcon, ...Continued, Unmatched, CMO, Renewable energy

SHANGRAO, China, Jan. 10, 2023 /PRNewswire/ -- JinkoSolar, one of the largest and most innovative solar module manufacturers in the world, today revealed its Second Generation Tiger Neo panel family – one of the world's most efficient and powerful solar panels.

Key Points: 
  • SHANGRAO, China, Jan. 10, 2023 /PRNewswire/ -- JinkoSolar, one of the largest and most innovative solar module manufacturers in the world, today revealed its Second Generation Tiger Neo panel family – one of the world's most efficient and powerful solar panels.
  • The upgraded Tiger Neo family includes three series with up to 445Wp for 54-cell, 615Wp for 72-cell, and 635Wp for 78-cell and module efficiency up to 22.27%, 23.23%, and 22.72% respectively.
  • This generation of Tiger Neo panels built on the record highly efficient N-type TOPCon technology delivers improved performance and reliability that results in:
    * One of the world's most efficient and powerful panels: Available with up to 23.23% efficiency at the module level, and 615Wp power output for the 72-cell panel in 182" format.
  • * Continued advances in bifacial factor: With up to an 85% bifacial factor, it can push a higher generation on the rear side panel and allow for 15-20% more yield compared to conventional bifacial panels.

Wellington College China wins HR Asia's 'Best Companies to Work for in Asia' Award three years running!

Retrieved on: 
Friday, December 30, 2022
Respect, Communication, Wellington College, Trial balance, Growth, Mentorship, Workplace, ...Continued, Culture, Integrity, Kindness, Policy, Management, Courage

Once again, Wellington College China is thrilled to announce that it has received HR Asia's 'Best Companies to Work for in Asia' Award for the third year in a row.

Key Points: 
  • Once again, Wellington College China is thrilled to announce that it has received HR Asia's 'Best Companies to Work for in Asia' Award for the third year in a row.
  • Julian Jeffrey, Chief Executive Master of Wellington College China, said: "The third time is a charm!
  • Earning this award once again is a benchmark achievement for Wellington College China and reflects the hard work of all our HR teams across the group.
  • Wellington College China schools have a culture founded on the Wellington Values of Courage, Respect, Integrity, Kindness and Responsibility.

Sensei Biotherapeutics Provides Update on Strategic Priorities

Retrieved on: 
Thursday, December 8, 2022
Max Planck Institute of Biochemistry, CD39, Investigational New Drug, Concluding observations on the second periodic report of the Holy See, Ludwig Maximilian University of Munich, Neoplasm, Max Planck Society, Tumor microenvironment, Amgen, Biochemistry, Chemistry, Daiichi Sankyo, Max Planck Institute of Neurobiology, FDA, Safety, Cancer, VISTA, Doctor of Philosophy, Schmidt Science Fellows, Workforce, Research, IND, Risk, OncoMed, ...Continued, Patient, Therapy, Vaccine, Pharmaceutical industry, Management, Sensei

BOSTON, Dec. 08, 2022 (GLOBE NEWSWIRE) -- eSensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced a streamlining and realignment of resources to support its key indications and programs, including its lead antibody, SNS-101, a conditionally active antibody targeting the immune checkpoint VISTA, as well as its other TMAb™ (Tumor Microenvironment Activated biologics) platform programs.

Key Points: 
  • Sensei plans to relocate any ongoing work at its Boston research site to its Rockville, Maryland site.
  • “Our Board of Directors and management team remain focused on ensuring that Sensei is well positioned to execute on our near-term clinical and preclinical milestones.
  • Prior to joining Sensei in 2019, Dr. van der Horst worked at Zenith Epigenetics Ltd., Igenica Biotherapeutics Inc., OncoMed Pharmaceuticals, Tularik, Inc. (now Amgen) and U3 Pharma GmbH (now Daiichi-Sankyo).
  • Sensei Biotherapeutics (Nasdaq: SNSE) is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients.

Organ Recovery Systems’ LifePort® Liver Transporter Preserves First Livers for Transplant as Part of the PILOT™ Continued Access Study

Retrieved on: 
Thursday, December 1, 2022
Biotechnology, FDA, Health, General Health, Health Technology, Medical Devices, Research, Hospitals, Surgery, Science, Clinical Trials, ...Continued, Robert Wood Johnson Medical School, HPB, Northwestern Memorial Hospital, DCD, Expense and cost recovery system, Hospital, AASLD, Multimedia, New Jersey Medical School, Transplant, Patient, Travel, Teaching hospital, HMP, Fatty liver disease, PILOT, Liver disease, LLT, Survival, ORS, FDA, Dentistry, Pharmaceutical industry

Organ Recovery Systems (ORS) is celebrating the first liver transplants using the LifePort Liver Transporter (LLT) with Vasosol at Rutgers Medical School in New Jersey and Northwestern Memorial Hospital in Chicago, Illinois.

Key Points: 
  • Organ Recovery Systems (ORS) is celebrating the first liver transplants using the LifePort Liver Transporter (LLT) with Vasosol at Rutgers Medical School in New Jersey and Northwestern Memorial Hospital in Chicago, Illinois.
  • View the full release here: https://www.businesswire.com/news/home/20221201005023/en/
    LifePort Liver Transporter is working to transform the preservation of donor livers.
  • Organ Recovery Systems is a global market-leading provider of organ preservation products and services, supporting 320 transplant programs across 43 countries.
  • Organ Recovery Systems proprietary LifePort platform has also been successfully designed to accommodate donor livers to help improve transplant outcomes for end-stage liver disease patients.

Capital Power announces 2023 financial targets, showcases its carbon reduction initiatives and highlights positive outlook at Investor Day

Retrieved on: 
Thursday, December 1, 2022
Carbon, Perception, Kilowatt-hour, CPX, Municipal district, Transport, Midcontinent Independent System Operator, Legislation, Climate, SEDAR, Coal, Wind, Genesee Generating Station, Policy, Natural gas, CCS, COVID-19, Repowering, AECO, Capital Power Corporation, Canada Infrastructure Bank, GAAP, ...Continued, Growth, EBITDA, Risk, Capital, Government, Annual report, FEED, Electricity, Webcast, News, MISO, CO2, Public expenditure, Acquisition, Natural borrowing limit, Labatt Brewing Company, TSX, Disclosure, Risk management, Federal, Investment, Oil, Renewable energy, Pet

Capital Power continues to advance its Genesee CCS project with the Board of Directors approval of a LNTP for the $2.3 billion project.

Key Points: 
  • Capital Power continues to advance its Genesee CCS project with the Board of Directors approval of a LNTP for the $2.3 billion project.
  • Capital Power (TSX: CPX) is a growth-oriented North American wholesale power producer with a strategic focus on sustainable energy headquartered in Edmonton, Alberta.
  • We have also made significant investments in carbon capture and utilization to reduce carbon impacts and are committed to be off coal in 2023.
  • Capital Power owns approximately 7,400 MW of power generation capacity at 28 facilities across North America.

EQS-News: PATRIZIA SE: Weaker markets impact PATRIZIA’s 9M 2022 EBITDA: AUM and recurring management fees still growing but FY 2022 guidance adjusted

Retrieved on: 
Friday, November 11, 2022
Investment, Nature, Seed, Income, Education, Social responsibility, Foundation, ...Continued, Total, AUM, Management, EBITDA, CFO, SE, EBITDAR, Growth, Life, CEO, EUR, News, Acquisition, Financial adviser, Security (finance), Bookkeeping, Bank, Real estate

PATRIZIA SE: Weaker markets impact PATRIZIAs 9M 2022 EBITDA: AUM and recurring management fees still growing but FY 2022 guidance adjusted

Key Points: 
  • PATRIZIA SE: Weaker markets impact PATRIZIAs 9M 2022 EBITDA: AUM and recurring management fees still growing but FY 2022 guidance adjusted
    The issuer is solely responsible for the content of this announcement.
  • Weaker markets impact PATRIZIAs 9M 2022 EBITDA: AUM and recurring management fees still growing but FY 2022 guidance adjusted
    Continued growth of AUM to EUR 57.1bn (31.12.2021: EUR 48.6bn; +17.4% y-t-d)
    Guidance 2022 adjusted to EBITDA of EUR 70.0 - 85.0m before reorganisation expenses, and EBITDA of EUR 60.0 - 75.0m, including reorganisation expenses
    Augsburg, 9 November 2022.
  • Assets under Management (AUM) and the associated recurring management fees continued to grow, almost offsetting the declines in transaction and performance fees.
  • Due to delayed investments, the guidance for growth in Assets under Management and for management fees for FY 2022 has to be adjusted as well, albeit to a relatively low degree.

ScreenCloud Launches ScreenCloud OS: The Missing Link for Smart Screens in the Digital Age

Retrieved on: 
Thursday, November 3, 2022
Other Manufacturing, Technology, Other Communications, Security, Communications, Manufacturing, Audio, Video, Networks, Hardware, Consumer Electronics, NTP, Workforce, Industry, OS, Amazon Fire tablet, ...Continued, DNS, Head, CEO, Organization, Longevity, RDM, RDM (lighting), Technology, News, Software, Communication, Solution, 3D printing, Online shopping, Video game console, Linux

Since 2015, ScreenCloud has recognized the untapped potential for screens and tailored its solutions to serve 9,000+ customers.

Key Points: 
  • Since 2015, ScreenCloud has recognized the untapped potential for screens and tailored its solutions to serve 9,000+ customers.
  • This technology is also imperative in reaching the global deskless and therefore digitally detached workforce.
  • Working across industries like manufacturing and logistics, these employees dont have regular access to traditional mediums like email, collaborative work applications, and intranets.
  • In an era of crowded and 'always-on' communication, screens can help companies simplify and broadcast information through a visually compelling, easy-to-use tool.

BCE reports third quarter 2022 results

Retrieved on: 
Thursday, November 3, 2022
GHG, Growth, Bell, Data monetization, DTC, ESG, Advertising, Solution, Maintenance, U.S. Securities and Exchange Commission, Forward-looking statement, Risk, Tax, ARPU, News, COVID-19, BCE, Telecommunication, Mental health, Failure, EBITDA, Research, Information technology, Bank, Consultant, Government, Second, DSP, Instability, Pacific Bell Wireless, Tablet, Annual report, Churn, IOT, Workplace, ...Continued, Mission statement, Climate change, SAM, Investment, Epidemic, NAS, Internet, Bell Media, Private Securities Litigation Reform Act, Adoption, Radio, Acquisition, OTT, Bell Let's Talk, Public expenditure, Pandemic, Bank of Canada, EPS, Bookkeeping, Risk management, Oil, Mobile phone, Crave, Distributel

The forward-looking statements contained in this news release describe our expectations as of November 3, 2022 and, accordingly, are subject to change after such date.

Key Points: 
  • The forward-looking statements contained in this news release describe our expectations as of November 3, 2022 and, accordingly, are subject to change after such date.
  • We caution that the foregoing list of risk factors is not exhaustive and other factors could also adversely affect our results.
  • We encourage investors to also read BCE's 2021 Annual MD&A dated March 3, 2022 (included in BCE's 2021 Annual Report) and BCE's 2022 First, Second and Third Quarter MD&As dated May 4, 2022, August 3, 2022 and November 2, 2022, respectively, for additional information with respect to certain of these and other assumptions and risks, filed by BCE with the Canadian provincial securities regulatory authorities (available at Sedar.com ) and with the U.S. Securities and Exchange Commission (available at SEC.gov ).
  • BCE is Canada's largest communications company, providing advanced Bell broadband wireless, Internet, TV, media and business communications services.